Summary:
Click image to enlargeHealthy adults aged 18 years and older are needed to participate in the study of a COVID-19 vaccine. The study will evaluate the safety of the vaccine and its ability to generate an immune response against COVID-19.
Qualified Participants Must:
• 18 years of age or older
•
Cannot have or had COVID-19
•
Willing and able to see doctor on site
Qualified Participants May Receive:
- Reimbursement for time and travel
- 56 weeks of study related treatment at no cost